Completed EARLY_PHASE1 INTERVENTIONAL 2-arm NCT04326985

RCT Mesenchymal Stem Cells Versus Hyaluronic Acid in OA Knee): (MSC)

A Randomized Control Clinical Trial to Evaluate the Efficacy of Intra-articular Injections of Mesenchymal Stem Cells Versus Hyaluronic Acid in Patients Affected by Osteoarthritis of the Knee

Sponsor: Chinese University of Hong Kong

Conditions Osteoarthritis, Knee

Interventions Autologous Mesenchymal Stem Cells Treatment (MSCs) Hyaluronic acid (HA)

Updated 5 times since 2020 Last updated: May 14, 2020 Started: Jan 31, 2015 Primary completion: Jan 30, 2019 Completion: Feb 28, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A EARLY_PHASE1 clinical study on Osteoarthritis, Knee, this trial is completed. The trial is conducted by Chinese University of Hong Kong and has accumulated 5 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed EARLY_PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed EARLY_PHASE1
Jun 2020 — Jan 2021 [monthly]

Completed EARLY_PHASE1
Apr 2020 — Jun 2020 [monthly]

Completed EARLY_PHASE1

First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chinese University of Hong Kong

Data source: Chinese University of Hong Kong

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hong Kong, Hong Kong